HIV testing of at risk patients in a large integrated health care system

Journal of General Internal Medicine

Volumn 22, Issue 3, 2007, Pages 315-320

  Owens, Douglas K ^a,b   Sundaram, Vandana ^a,b   Lazzeroni, Laura C ^b   Douglass, Lena R ^a   Tempio, Patricia ^a   Holodniy, Mark ^a,b   Sanders, Gillian D ^b,c   Shadle, Vera M ^d   McWhorter, Valerie C ^e   Agoncillo, Teodora ^e   Haren, Noreen ^f   Chavis, Darlene ^f   Borowsky, Leila H ^a   Yano, Elizabeth M ^g,h   Jensen, Peter ^d   Simberkoff, Michael S ^f   Bozzette, Samuel A ^e  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV; Risk factors; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DOCUMENTATION; FEMALE; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREVALENCE; RETROSPECTIVE STUDY; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; GOVERNMENT; INTEGRATED HEALTH CARE SYSTEM; MASS SCREENING; METHODOLOGY; MIDDLE AGED; RISK FACTOR; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 34250327961     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-006-0028-9     Document Type: Article

References (29)

1. Palella FJ, Jr., Deloria-Knoll M, Chmiel JS, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138(8):620-6.
2. Palella FJ, Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998;338(13):853-60.
3. Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352(6):570-85.
4. Crepaz N, Lyles CM, Wolitski RJ, et al. Do prevention interventions reduce HIV risk behaviors among people living with HIV? A meta-analytic review of controlled trials. AIDS. 2006;20(2):143-57.
5. Kamb ML, Fishbein M, Douglas JM, Jr., et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA. 1998;280(13):1161-7.
6. DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk-reduction intervention for young African-American women. JAMA. 1995;274(16):1271-6.
7. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446-53.
8. Walensky RP, Weinstein MC, Kimmel AD, et al. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med. 2005;118(3):292-300.
9. Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States-an analysis of cost-effectiveness. N Engl J Med. 2005;352(6):586-95.
10. Fleming PL, Byers RH, Sweeney PA, Daniels D, Karon JM, Janssen RM. HIV Prevalence in the United States, 2000. Final Program and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, February 24-28, 2002. Alexandria, Virginia: Foundation for Retrovirology and Human Health.
11. Centers for Disease Control and Prevention. Advancing HIV Prevention: New Strategies for a Changing Epidemic. Vol. Accessed on August 30, 2004: http://www.cdc.gov/hiv/partners/AHP/ahp_October03.pdf.
12. Neal JJ, Fleming PL. Frequency and predictors of late HIV diagnosis in the United States, 1994 through 1999. 9th Conference on Retroviruses and Opportunistic Infections. Seattle, Washington; 2002.
13. Klein D, Hurley LB, Merrill D, Quesenberry CP, Jr. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr. 2003;32(2):143-52.
14. Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS. 2001;15(1):77-85.
15. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17; quiz CE1-4.
16. Kerr EA, Gerzoff RB, Krein SL, et al. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med. 2004;141(4):272-81.
17. Jha AK, Perlin JB, Kizer KW, Dudley RA. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med. 2003;348(22):2218-27.
18. Asch SM, McGlynn EA, Hogan MM, et al. Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med. 2004;141(12):938-45.
19. Center for Quality Management in Public Health. (U.S. Department of Veterans Affairs, Public Health Strategic Health Care Group, Center for Quality Management in Public Health). Caring for Veterans with HIV Disease: Characteristics of Veterans in VA Care, Fiscal Year 2002. 2003.
20. Backus L, Mole L, Chang S, Deyton L. The immunology case registry. J Clin Epidemiol. 2001;54 Suppl 1:S12-5.
21. The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). 4th edition. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Health Care Financing Administration; 1991.
22. Gandhi N, Skanderson M, Gordon K, Concato J, Justice A. Delayed Presentation for HIV Care Among Veterans: An Opportunity for Intervention. 13th Conference on Retroviruses and Opportunistic Infections. Denver, Colorado, USA; 2006.
23. Lopez J, Welvaart H, Ford W, Kerndt P. HIV prevalence and risk behaviors among patients attending Los Angeles County Tuberculosis Clinics: 1993-1996. Ann Epidemiol. 1998;8(3):168-74.
24. Shlay JC, Blackburn D, O'Keefe K, Raevsky C, Evans M, Cohn DL. Human immunodeficiency virus seroprevalence and risk assessment of a homeless population in Denver. Sex Transm Dis. 1996;23(4):304-11.
25. Woods WJ, Lindan CP, Hudes ES, Boscarino JA, Clark WW, Avins AL. HIV infection and risk behaviors in two cross-sectional surveys of heterosexuals in alcoholism treatment. J Stud Alcohol. 2000;61(2):262-6.
26. Kurata J, Ounanian L, Chetkovich D, Taylor A, Yates D, Werblun M. Seroprevalence of human immunodeficiency virus among family practice outpatients. J Am Board Fam Pract. 1993;6(4):347-52.
27. Sundaram V, Douglass LR, Lazzeroni LC, Sanders GD, Tempio P, Bergen MR. A randomized trial of an intervention to improve HIV Screening (Abstract). Med Decis Making. 2002;22(6):542.
28. Rotheram-Borus MJ, Leibowitz AA, Etzel MA. Routine, rapid HIV testing. AIDS Educ Prev. 2006;18(3):273-80.
29. Asch SM, Kerr EA, Keesey J, et al. Who is at greatest risk for receiving poor-quality health care? N Engl J Med. 2006;354(11):1147-56.